Deborah M. Reiner Sells 723 Shares of HCA Healthcare Inc (HCA) Stock

Share on StockTwits

HCA Healthcare Inc (NYSE:HCA) SVP Deborah M. Reiner sold 723 shares of the firm’s stock in a transaction dated Monday, November 5th. The stock was sold at an average price of $135.06, for a total transaction of $97,648.38. Following the completion of the sale, the senior vice president now owns 6,184 shares of the company’s stock, valued at $835,211.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

HCA stock opened at $135.24 on Wednesday. HCA Healthcare Inc has a 52-week low of $74.26 and a 52-week high of $141.11. The company has a market cap of $46.52 billion, a PE ratio of 15.11, a price-to-earnings-growth ratio of 1.18 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The company had revenue of $11.45 billion during the quarter, compared to analyst estimates of $11.29 billion. During the same period in the previous year, the business earned $1.13 EPS. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. As a group, sell-side analysts predict that HCA Healthcare Inc will post 9.35 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be issued a $0.35 dividend. The ex-dividend date is Friday, November 30th. This represents a $1.40 dividend on an annualized basis and a yield of 1.04%. HCA Healthcare’s payout ratio is currently 21.24%.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Kendall Capital Management raised its holdings in HCA Healthcare by 5.2% in the 3rd quarter. Kendall Capital Management now owns 8,250 shares of the company’s stock worth $1,148,000 after acquiring an additional 405 shares during the last quarter. Smithfield Trust Co. raised its holdings in HCA Healthcare by 41.2% in the 3rd quarter. Smithfield Trust Co. now owns 1,405 shares of the company’s stock worth $196,000 after acquiring an additional 410 shares during the last quarter. Motley Fool Asset Management LLC raised its holdings in HCA Healthcare by 12.5% in the 2nd quarter. Motley Fool Asset Management LLC now owns 3,720 shares of the company’s stock worth $382,000 after acquiring an additional 412 shares during the last quarter. DNB Asset Management AS raised its holdings in HCA Healthcare by 1.1% in the 3rd quarter. DNB Asset Management AS now owns 36,357 shares of the company’s stock worth $5,058,000 after acquiring an additional 413 shares during the last quarter. Finally, Banque Pictet & Cie SA raised its holdings in HCA Healthcare by 0.5% in the 2nd quarter. Banque Pictet & Cie SA now owns 91,929 shares of the company’s stock worth $9,432,000 after acquiring an additional 480 shares during the last quarter. Institutional investors own 70.84% of the company’s stock.

Several brokerages have commented on HCA. Credit Suisse Group raised their price objective on shares of HCA Healthcare from $156.00 to $165.00 and gave the stock an “outperform” rating in a report on Thursday, November 1st. Argus set a $155.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a report on Tuesday. SunTrust Banks lifted their target price on shares of HCA Healthcare to $145.00 and gave the company a “buy” rating in a report on Thursday, July 26th. Jefferies Financial Group lifted their target price on shares of HCA Healthcare from $155.00 to $158.00 and gave the company a “buy” rating in a report on Wednesday, October 31st. Finally, ValuEngine upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a report on Wednesday, July 18th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $141.53.

TRADEMARK VIOLATION WARNING: “Deborah M. Reiner Sells 723 Shares of HCA Healthcare Inc (HCA) Stock” was first posted by Week Herald and is the sole property of of Week Herald. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://weekherald.com/2018/11/07/deborah-m-reiner-sells-723-shares-of-hca-healthcare-inc-hca-stock.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: Hedge Funds – How They Work For Investors

Insider Buying and Selling by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply